(Q33450059)

26 July 2017

Phase I study of recombinant human tumor necrosis factor (English)

1 reference

26 July 2017

K Kimura

1

1 reference

26 July 2017

T Taguchi

2

1 reference

26 July 2017

I Urushizaki

3

1 reference

26 July 2017

R Ohno

4

1 reference

26 July 2017

O Abe

5

1 reference

26 July 2017

H Furue

6

1 reference

26 July 2017

T Hattori

7

1 reference

26 July 2017

H Ichihashi

8

1 reference

26 July 2017

K Inoguchi

9

1 reference

26 July 2017

H Majima

10

1 reference

26 July 2017

1 January 1987

1 reference

Cancer Chemotherapy and Pharmacology

26 July 2017

1 reference

26 July 2017

20

1 reference

26 July 2017

223-229

1 reference

26 July 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00570490

26 July 2017

0 references

cites work

Effect of recombinant human tumor necrosis factor on the colony growth of human leukemia progenitor cells and normal hematopoietic progenitor cells.

1 reference

12 December 2020

Recombinant Leukocyte A Interferon: Pharmacokinetics, Single-Dose Tolerance, and Biologic Effects in Cancer Patients

1 reference

12 December 2020

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

1 reference

12 December 2020

Rabbit tumor necrosis factor: mechanism of action.

1 reference

12 December 2020

Cytotoxic effect of tumor necrosis factor on human lymphocytes and specific binding of the factor to the target cells

1 reference

12 December 2020

Phase I study of weekly high-dose human lymphoblastoid interferon

1 reference

12 December 2020

Tumour-necrosis factor from the rabbit. I. Mode of action, specificity and physicochemical properties

1 reference

12 December 2020

Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor

1 reference

12 December 2020

A phase I study of human lymphoblastoid interferon administered by continuous intravenous infusion

1 reference

12 December 2020

Tumor necrosis factor (TNF).

1 reference

12 December 2020

Clinical toxicity of interferons in cancer patients: a review

1 reference

12 December 2020

Identity of tumour necrosis factor and the macrophage-secreted factor cachectin

1 reference

12 December 2020

Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin

1 reference

12 December 2020

Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon

1 reference

12 December 2020

Endotoxin induced 'tumour-necrosis serum' kills a subpopulation of normal lymphocytes in vitro

1 reference

12 December 2020

Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon

1 reference

12 December 2020

Phase I trial of recombinant interferon gamma in cancer patients

1 reference

12 December 2020

An endotoxin-induced serum factor that causes necrosis of tumors

1 reference

12 December 2020

Clinical and laboratory investigations on man: systemic administration of potent interferon to man.

1 reference

12 December 2020

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

1 reference

12 December 2020

Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.

1 reference

12 December 2020

Treatment of multiple myeloma with recombinant human leukocyte A interferon

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00570490

1 reference

Dimensions Publication ID

26 July 2017

1032993151

0 references

Fatcat ID

release_5bassjbssjfmpgorlmurmunpjy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5bassjbssjfmpgorlmurmunpjy

24 November 2022

mapped directly with Wikidata item

1 reference